133 related articles for article (PubMed ID: 38166380)
1. Degradation and Erosion of Metal-Organic Frameworks: Comparative Study of a NanoMIL-100 Drug Delivery System.
Vuong MDL; Horbenko Y; Frégnaux M; Christodoulou I; Martineau-Corcos C; Levitz P; Rollet AL; Gref R; Haouas M
ACS Appl Mater Interfaces; 2024 Jan; 16(2):2086-2100. PubMed ID: 38166380
[TBL] [Abstract][Full Text] [Related]
2. NanoMIL-100(Fe) containing docetaxel for breast cancer therapy.
Rezaei M; Abbasi A; Varshochian R; Dinarvand R; Jeddi-Tehrani M
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1390-1401. PubMed ID: 28838252
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
[TBL] [Abstract][Full Text] [Related]
4. Studies on metal-organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension.
Mohamed NA; Abou-Saleh H; Kameno Y; Marei I; de Nucci G; Ahmetaj-Shala B; Shala F; Kirkby NS; Jennings L; Al-Ansari DE; Davies RP; Lickiss PD; Mitchell JA
Sci Rep; 2021 Feb; 11(1):4336. PubMed ID: 33619326
[TBL] [Abstract][Full Text] [Related]
5. Outstanding Drug-Loading/Release Capacity of Hollow Fe-Metal-Organic Framework-Based Microcapsules: A Potential Multifunctional Drug-Delivery Platform.
Cui R; Zhao P; Yan Y; Bao G; Damirin A; Liu Z
Inorg Chem; 2021 Feb; 60(3):1664-1671. PubMed ID: 33434431
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
[TBL] [Abstract][Full Text] [Related]
7. Thermal Stimuli-Triggered Drug Release from a Biocompatible Porous Metal-Organic Framework.
Jiang K; Zhang L; Hu Q; Zhang Q; Lin W; Cui Y; Yang Y; Qian G
Chemistry; 2017 Jul; 23(42):10215-10221. PubMed ID: 28682004
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Delivery on Metal-Organic Frameworks: The Effect of the Metal Center on Pharmacokinetics within the M-MOF-74 Family.
Lawson S; Newport K; Pederniera N; Rownaghi AA; Rezaei F
ACS Appl Bio Mater; 2021 Apr; 4(4):3423-3432. PubMed ID: 35014426
[TBL] [Abstract][Full Text] [Related]
9. Iron-Based Metal-Organic Frameworks in Drug Delivery and Biomedicine.
Liu X; Liang T; Zhang R; Ding Q; Wu S; Li C; Lin Y; Ye Y; Zhong Z; Zhou M
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9643-9655. PubMed ID: 33606494
[TBL] [Abstract][Full Text] [Related]
10. Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution.
Abazari R; Reza Mahjoub A; Slawin AMZ; Carpenter-Warren CL
Ultrason Sonochem; 2018 Apr; 42():594-608. PubMed ID: 29429708
[TBL] [Abstract][Full Text] [Related]
11. New insights into the degradation mechanism of metal-organic frameworks drug carriers.
Li X; Lachmanski L; Safi S; Sene S; Serre C; Grenèche JM; Zhang J; Gref R
Sci Rep; 2017 Oct; 7(1):13142. PubMed ID: 29030570
[TBL] [Abstract][Full Text] [Related]
12. A Nanocomposite Vehicle Based on Metal-Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery.
Zhou Y; Liu L; Cao Y; Yu S; He C; Chen X
ACS Appl Mater Interfaces; 2020 May; 12(20):22581-22592. PubMed ID: 32340452
[TBL] [Abstract][Full Text] [Related]
13. Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization.
Unamuno X; Imbuluzqueta E; Salles F; Horcajada P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2018 Nov; 132():11-18. PubMed ID: 30179739
[TBL] [Abstract][Full Text] [Related]
14. Internalization of Metal-Organic Framework Nanoparticles in Human Vascular Cells: Implications for Cardiovascular Disease Therapy.
Al-Ansari DE; Mohamed NA; Marei I; Zekri A; Kameno Y; Davies RP; Lickiss PD; Rahman MM; Abou-Saleh H
Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32471187
[No Abstract] [Full Text] [Related]
15. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
16. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
17. Advanced Characterization Methodology to Unravel the Biodegradability of Metal-Organic Framework Nanoparticles in Extremely Diluted Conditions.
Christodoulou I; Patriarche G; Serre C; Boissiére C; Gref R
ACS Appl Mater Interfaces; 2024 Mar; 16(11):14296-14307. PubMed ID: 38452344
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier.
Chen G; Luo J; Cai M; Qin L; Wang Y; Gao L; Huang P; Yu Y; Ding Y; Dong X; Yin X; Ni J
Molecules; 2019 Sep; 24(18):. PubMed ID: 31527488
[TBL] [Abstract][Full Text] [Related]
19. pH and H
Zhao H; Zhao Y; Liu D
ACS Appl Bio Mater; 2021 Sep; 4(9):7103-7110. PubMed ID: 35006942
[TBL] [Abstract][Full Text] [Related]
20. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
